Clinical Trial

CorEvitas Inflammatory Bowel Disease (IBD) Registry

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-05-18; most recent amendment 2025-09-29.
Status change: Recruiting → Enrolling by Invitation 2025-09-29
Status change: Enrolling by Invitation → Recruiting 2024-07-15
Trial Details
NCT Number NCT03162549
Lead Sponsor CorEvitas
Conditions Inflammatory Bowel Diseases
Enrollment 2,287 participants
Start Date 2017-03-27
Primary Completion 2100-12 (estimated)
Study Completion 2100-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-02